Myofibroblastic tumors are still serious, with a high recurrence rate and severely shortened survival. Myofibroblastic tumors are mainly composed of spindle cells and are formed by plasma cells. They are most common in children and adolescents, and most frequently occur in the lungs and mesentery. The most common sites are lungs, mesentery, etc. Clinically, systemic symptoms may appear, its malignant degree is very high, and the effect of treatment is relatively poor. Most of the patients with early-stage myofibroblastoma can be healed after active treatment, but due to the high degree of recurrence of the tumor, a considerable part of the population recurs again after treatment, and the cure is not achieved repeatedly. Moreover, advanced myofibroblastoma has already metastasized, which can control the related symptoms to a limited extent after cooperating with chemotherapy, radiotherapy, targeted drug therapy and other therapeutic measures.